NasdaqGS - Delayed Quote USD

Silk Road Medical, Inc (SILK)

Compare
27.01 -0.03 (-0.11%)
At close: 4:00 PM EDT
27.00 -0.01 (-0.04%)
After hours: 4:30 PM EDT
Loading Chart for SILK
DELL
  • Previous Close 27.04
  • Open 27.04
  • Bid 19.47 x 200
  • Ask 34.62 x 200
  • Day's Range 27.01 - 27.06
  • 52 Week Range 6.08 - 27.19
  • Volume 1,601,987
  • Avg. Volume 1,651,364
  • Market Cap (intraday) 1.097B
  • Beta (5Y Monthly) 1.53
  • PE Ratio (TTM) --
  • EPS (TTM) -1.37
  • Earnings Date Jul 31, 2024 - Aug 5, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 22.58

Silk Road Medical, Inc operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization (TCAR). Its products comprise ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and establish temporary blood flow reversal; ENROUTE Transcarotid Stent System for transcarotid access; ENHANCE Transcarotid Peripheral Access Kit, which is used to gain initial access to the common carotid artery; ENROUTE 0.014 Guidewire for atraumatic vessel navigation and target lesion crossing for delivery of interventional devices; and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter, a transcarotid rapid exchange balloon for the TCAR procedure. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.

silkroadmed.com

474

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SILK

View More

Performance Overview: SILK

Trailing total returns as of 7/31/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

SILK
120.13%
S&P 500
15.78%

1-Year Return

SILK
16.67%
S&P 500
20.52%

3-Year Return

SILK
46.17%
S&P 500
25.64%

5-Year Return

SILK
34.14%
S&P 500
83.27%

Compare To: SILK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SILK

View More

Valuation Measures

Annual
As of 7/30/2024
  • Market Cap

    1.10B

  • Enterprise Value

    1.00B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.69

  • Price/Book (mrq)

    7.46

  • Enterprise Value/Revenue

    5.40

  • Enterprise Value/EBITDA

    -12.84

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -28.80%

  • Return on Assets (ttm)

    -13.99%

  • Return on Equity (ttm)

    -35.04%

  • Revenue (ttm)

    185.49M

  • Net Income Avi to Common (ttm)

    -53.42M

  • Diluted EPS (ttm)

    -1.37

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    174.46M

  • Total Debt/Equity (mrq)

    57.41%

  • Levered Free Cash Flow (ttm)

    -16.75M

Research Analysis: SILK

View More

Earnings Per Share

Consensus EPS
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

8.00 Low
22.58 Average
27.01 Current
27.50
 

Company Insights: SILK

Research Reports: SILK

View More
  • Downgrading to SELL

    Based in Sunnyvale, California, Silk Road Medical is a medical device company focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR combines the surgical principles of neuroprotection with minimally invasive endovascular techniques to treat carotid artery blockages that may cause strokes.

    Rating
    Price Target
     
  • Solid Second Quarter Amid Signs of Slowing Activity History will

    Solid Second Quarter Amid Signs of Slowing Activity History will record a good start to 2024, with the S&P 500 up 15% in the first six months. However, it was not all sunshine and roses. After generally rising across the first quarter, stocks fell in April. Heading into May, the gain in the S&P 500 had been cut to 7%. From May 1 to mid-June, the Nasdaq soared 17%; and the S&P 500 rose 13%. If you annualize those returns, the Nasdaq was on track for a 110% annual gain and the S&P 500 for a 70% annual gain. After consolidating those gains in the final two weeks of June, the stock market took off again to open July - normally a good market month. Plainly, the mood has shifted to anticipating the Fed beginning to cut rates this year as inflation continues to decline. Environment: Second-Quarter 2024 The U.S. stock market extended its first-quarter 2024 momentum into the second quarter, but gains were muted by an April stumble and some narrowing in sector breadth compared with 1Q24. After advancing 10.6% on a total-return basis (with dividends) in 1Q24, the S&P 500 posted 2Q24 total return of 4.1%, while rising from 5,254 at the end of March 2024 to 5,460 at the end of June. The quarter started with a 'cruel' April, in which the S&P 500 slid 3%. Interest rates spiked in the fourth month, as March data suggested that the fight against inflation had bogged down. The index posted identical 3.5% gains in May and June, as improving inflation trends rekindled rate-cut optimism. The Fed held rates steady at its June 2024 meeting, as it has done at every FOMC meeting since July 2023. Following the May FOMC meeting, the Fed noted 'a lack of further progress' toward the Committee's 2% inflation objective. The language in the June FOMC report, by contrast, noted 'modest further progress' toward the Committee's target. The Fed started to hike rates more than two years ago based on the perception that pricing pressures were mainly tied to the supply-chain crisis and could be quickly subdued. Stubbornly high costs for shelter and service components, including vehicle insurance, have underscored that inflation is about far more than the supply chain. The Fed's preferred inflation gauge, the core PCE price index, rose 0.1% in May and was up 2.6% year over year. That was the lowest annual rate of change in the core PCE price index since March 2021, which was also the first time in the current economic cycle that inflation topped the Fed's 2% target. The core PCE data confirmed inflation inputs from May CPI and PPI reported earlier in June. May core CPI was up 0.2% month over month, the lowest since June 2023. Overall improvement in inflation is allowing market rates of interest to move down from spring peaks, even though they remain above optimistically low levels at the beginning of 2024. The 10-year Treasury yield was 4.29% at the end of June, down from 4.41% at the end of May and peak levels of 4.63% as of the end of April. The two-year Treasury yield was 4.70% as of end of June, down 4.82% at the end of May and the peak level of 4.96% as of end of April. After showing signs of moderation for much of 2023, the jobs economy sustained year-end 2023 strength across the first half of 2024. The U.S. economy delivered 206,000 new jobs in June, above the consensus of 190,000. June's increase in payrolls and revisions lower to results from May and April took the three-month average to 177,000, below the 12-month average of 220,000. The unemployment rate rose to 4.1% for June, and is now at the level the Fed would prefer to see before beginning its rate-cutting campaign. Average hourly earnings increased 10 cents month to month and are 3.9% higher year over year (compared to 4.1% in May). Annual wage growth continues to run above inflation, but the premium has narrowed. The industrial economy continues to send mixed signals. Industrial Production for May rose 0.9% month-over-month, much better than the 0.3% consensus forecast and up from no growth in April. May capacity utilization was still below the long-run average, but was up half a point from April. Supply-chain executives in the manufacturing sector expressed cautious optimism in spring 2024, but it did not last. For June 2024, the ISM manufacturing PMI index came in at 48.5%, down from 48.7% in May and 50.3% in April. ISM's manufacturing PMI has been below 50% for 19 of the past 20 months. After several years of adding workers as fast as they could, manufacturers are now engaging in targeted layoffs. Order growth has slowed in areas including metal fabrication and transportation equipment, while rising in areas such as computers & electronic products. The ISM services PMI unexpectedly dipped to 48.8% for June from 53.8% in May. While this was just the third time the services sector contracted in the past 49 month, it was also the second sub-50 reading in just the past three months. That is of concern, given that the services economy is several time the size of the manufacturing economy. Signals from the consumer economy also remain mixed. Retail sales in May edged up just 0.1% from April, when sales declined 0.2%. On a year-over-year basis, retail sales in May 2024 were up 2.3%; that is down from consistent mid- to high-single-digit annual growth across 2023. Straddling the commercial and consumer economies is housing. Both existing home sales and new home sales as of spring 2024 were running at about 62% of peak pandemic-infused levels from 2020-2022. Housing likely is frozen in place until mortgage rates begin coming down. First-quarter GDP grew at a disappointing 1.4% annual rate. Personal consumption expenditures (PCE) for 1Q24 increased 1.5% while non-residential fixed investment (a proxy for corporate capital spending) rose 4.4%. Together, these two components make up over 80% of GDP. S&P 500 earnings for 1Q24 (reported from mid-April to mid-May) rose in high-single-digit year-over-year percentages, marking a third consecutive quarter of annual EPS growth. Around 80% of companies exceeded consensus expectations for 1Q24 EPS versus 70%-75% on average. The magnitude of the beat was at the high end of the 5%-8% historical range. As of the end of 1Q24, the S&P 500 was a few ticks ahead of the Nasdaq Composite. That changed in 2Q24, as Nasdaq raced ahead for an 18.6% total return as of mid-year, versus 15.3% for the S&P 500. Information Technology was the fourth-place sector for 1Q24 and lagged the S&P 500. That too changed in the second quarter. Information Technology led the market with a 28% gain at mid-year, just ahead of 27% for Communication Services. While only those two sectors were ahead of the S&P 500 at mid-year 2024, multiple sectors - including Energy, Financial, Utilities, Consumer Staples, and Healthcare - were beating or just below the S&P 500's average annual appreciation, which has been right around 10% since 1980. The Consumer Discretionary sector, one of the top-three performers in 2023, was ninth among 11 sectors in the 2024 first half. The reality of weak consumer goods spending was evident in the 1Q24 GDP report as well as in April and May retail spending. After a worrisome level of AI-driven sector concentration in 2023, the market experienced much-better breadth in 1Q24. A refocus on growth sectors and AI led to a narrowing in the advance in 2Q24. But breadth at mid-year 2024 was still better than it was at mid-year 2023. Conclusion In broad terms, the nearly two-year rally in stocks is a good thing. Investors are in the green; with fewer losers, they do not need to sell underwater positions and thus weaken rallies. Also in broad terms, the nearly two-year rally in stocks is too narrow. The risk of investor concentration has been amplified by AI mania. In 2023, three sectors - Communication Services, Technology, and Consumer Discretionary - accounted for most of the year to date advance. This year, we are down to two sectors - Communication Services and Technology. In addition to sector concentration, this rallying market is characterized by individual stock concentration. As AI mania gripped the stock market, the 'Magnificent Seven' of assumed AI beneficiaries dominated the rally. These seven stocks are Nvidia, Microsoft, Alphabet, Meta Platforms, Amazon, Apple, and Tesla. As of May 2024, these stocks represented 29% of total S&P 500 market capitalization. When a single sector or a single cluster of stocks is dominant, it usually does not end well. Past examples include Energy, which is now one-quarter its peak market weight; and Apple, which was unstoppable in the early days of iPhones but has stumbled multiple times since. The Street is divided as to how long the seven can remain magnificent. Given that the age of generative AI has only just begun, Argus believes these names and other perceived AI winners could lead the market over the next several years.

     
  • Daily – Vickers Top Buyers & Sellers for 07/09/2024

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

     
  • Argus Quick Note: Weekly Stock List for 07/01/2024: Shooting Stars and Falling Angels in 2Q24

    The second quarter of 2024 was rewarding for equity investors, as the S&P 500 increased another 4% and has gained almost 15% year to date. Growth was the segment leader in 2Q, as the S&P 500 Growth Index advanced approximately 8% in the period while the S&P 500 Value Index declined slightly. Leading sectors included Information Technology and Communication Services, while sectors in the red for the past three months included Real Estate, Materials, Industrials, Financial, and Energy. The average stock in the Argus Universe of Coverage declined 2.4% during the quarter, while the median stock dropped 3.0%. The average BUY-rated stock declined 0.7%, while the average HOLD-rated stock gained 6.7%. Will the rally broaden in 2H24, or will investors keep focusing on Tech and Communications groups? Will small-caps pick up their pace (the Russell 2000 was up 1.8% in 1H24), or is the current bull market rally due for a break, with some profit-taking coming into play? Given declining interest rates, we expect growth stocks to continue to carry the bull market, while the risk of recession puts a premium on clean balance sheets, which are also more prevalent among large-caps. Investors seeking value are encouraged to focus on dividends and look for yields in the 3-4% range. Here are the top 10 performers from the Argus Universe last quarter, including, somewhat surprisingly, representatives of five of the 11 major sectors, as well as the five worst performers.

     

People Also Watch